Princeton West Innovation Center Hopewell, NJ

Execute CA

The Offering

Address

311 Pennington Rocky Hill Road
Pennington, NJ 08534

As exclusive agents and joint advisors, Cushman & Wakefield and Newmark are pleased to present Princeton West Innovation Campus (PWIC) for sale. Formerly serving as the HQ for Bristol-Myers Squibb (late 1990’s to 2020), this world-class biopharmaceutical R&D and manufacturing campus totals 854,421 SF and has been the beneficiary of over $600MM worth of capital investment since it’s inception. Most notably, the campus is supported by a robust central utility complex, arguably the most critical real estate component to end-user success in the lab and biotech industry by ensuring “speed to market” vs. competition. The extraordinary on-site infrastructure at PWIC has resulted in high leasing velocity (Gennao, GenScript ProBio, Enzene, among others) and user-purchaser activity (ie. Beigene) and makes it a truly “one-of-one” option for users seeking full-service lab, pharmaceutical manufacturing and R&D capabilities. 

In addition, the site has the ability to support upwards of +/-89MW of power (35MW readily available) to accommodate data center uses. 


Low Risk / High Upside

• 854,421 sq. ft. campus on 391 acres with 30 buildings.

• 82% leased to six tenants, 10.6-year WALT, $35.84 PSF rent.

• $10.8 million invested since 2020; 380,432 sq. ft. leased.

• Potential for lab conversion, increasing NOI by 3X.

• PILOT agreement potential and approvals for 234,180 sq. ft. of new buildings.

• Strong lease-up, repositioning, and development opportunities with stable cash flow.


Investment Highlights

• UNMATCHED INFRASTRUCTURE + POWER SUPPLY

• PROVEN PRINCETON ADDRESS FOR LAB, R&D, AND PHARMA MANUFACTURING

• ACCESS TO GLOBALLY RECOGNIZED EDUCATION & TALENT POOL

• APPROVED EXPANSION PLANS + DEVELOPMENT OPTIONALITY

Location Map

Sales Inquiries

 

DAVID W. BERNHAUT
Executive Vice Chairman
+ 1 201 460 3356
david.bernhaut@cushwake.com

H. GARY GABRIEL
Executive Vice Chairman
+ 1 201 460 3352
gary.gabriel@cushwake.com

ANDREW MERIN
Executive Vice Chairman
+ 1 201 460 3358
andrew.merin@cushwake.com

FRANK A. DITOMMASO II
Executive Director
+ 1 201 508 5303
frank.ditommaso@cushwake.com

SETH ZUIDEMA
Associate Director
+ 1 201 508 5321
seth.zuidema@cushwake.com

MAIA SIRABIAN
Financial Analyst
+ 1 201 347 4871
maia.sirabian@cushwake.com


NEWMARK


ADAM SPIES
Co-Lead Capital Markets
+ 1 917 446 2096
adam.spies@nmrk.com

JOSHUA A. KING
Executive Vice Chairman
+ 1 917 399 5980
josh.king@nmrk.com

EDWARD MAHER
Executive Vice Chairman
+ 1 617 863 8611
edward.maher@nmrk.com

ROBERT GRIFFIN
Co-Head of U.S. Capital
+ 1 617 863 8612
robert.griffin@nmrk.com

STEVEN GOLUBCHICK
President, West Region
+ 1 415 445 5130
steven.golubchick@nmrk.com

ALEX FREED
Analyst
+ 1 202 725 6965
alexander.freed@nmrk.com